Original Article
Journal of Cerebral Blood Flow & Metabolism (2007) 27, 1431–1443; doi:10.1038/sj.jcbfm.9600445; published online 24 January 2007
The NMDA and AMPA/KA receptors are involved in glutamate-induced alterations of occludin expression and phosphorylation in brain endothelial cells
This work was supported by NIH (MH63022, MH072567, NS39254, and AA013843).
Ibolya E András1, Mária A Deli2, Szilvia Veszelka2, Kentaro Hayashi1, Bernhard Hennig3 and Michal Toborek1
- 1Molecular Neuroscience and Vascular Biology Laboratory, Department of Surgery, University of Kentucky Medical Center, Lexington, Kentucky, USA
- 2Biological Research Center, Szeged, Hungary
- 3College of Agriculture, University of Kentucky, Lexington, Kentucky, USA
Correspondence: Dr M Toborek, Molecular Neuroscience and Vascular Biology Laboratory, Department of Surgery/Neurosurgery, University of Kentucky Medical Center, 800 Rose Street, Lexington, Kentucky 40536, USA. E-mail: michal.toborek@uky.edu
Received 8 March 2006; Revised 11 September 2006; Accepted 14 November 2006; Published online 24 January 2007.
Abstract
Glutamate levels increase dramatically in cerebral ischemia and stroke. This may lead to opening of the blood–brain barrier (BBB) and induce further brain damage. Because endothelial tight junctions are critical elements of the BBB integrity, the aim of this study was to investigate the mechanisms of glutamate-induced alterations of the tight-junction protein occludin in cultured brain microvascular endothelial cells (BMECs). Transient exposure to glutamate resulted in cellular redistribution of occludin, followed by a decrease in the total level of this protein and diminished barrier function of BMECs. Inhibition of the N-methyl-D-aspartate (NMDA) or alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate (AMPA/KA) receptors attenuated glutamate-induced changes in occludin redistribution but not in the total protein levels. Treatment with glutamate also increased tyrosine phosphorylation and decreased threonine phosphorylation of occludin. Inhibition of the NMDA receptors by MK-801 partially protected against glutamate-induced elevation of occludin tyrosine phosphorylation. In addition, pretreatment with MK-801-attenuated glutamate-mediated disruption of endothelial barrier function. Blocking of the AMPA/KA receptors by 6,7-dinitroquinoxaline-2.3-dione (DNQX) protected against hypophosphorylation of threonine residues of occludin; however, it did not affect disruption of endothelial integrity. These findings indicate the opposite effects of the NMDA and AMPA/KA receptors on occludin phosphorylation and disruption of the BBB functions.
Keywords:
blood–brain barrier, glutamate receptors, occludin, phosphorylation, tight junction
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
The NMDA and AMPA/KA receptors are involved in glutamate-induced alterations of occludin expression and phosphorylation in brain endothelial cellsJournal of Cerebral Blood Flow & Metabolism Original Article
Excitotoxic Mechanisms of Ischemic Injury in Myelinated White MatterJournal of Cerebral Blood Flow & Metabolism Original Article
Ionotropic Glutamate Receptors in Cerebral Microvascular Endothelium Are Functionally Linked to Heme OxygenaseJournal of Cerebral Blood Flow & Metabolism Original Article
Identification of neuroprotective properties of anti-MAG antibody: a novel approach for the treatment of stroke?Journal of Cerebral Blood Flow & Metabolism Original Article
See all 48 matches for Research
